Spindle Cell/Sclerosing Rhabdomyosarcoma With PAX8::PPARG Fusion

被引:2
|
作者
Rakheja, Dinesh [1 ,3 ]
Park, Jason Y. [1 ,3 ]
Alhasan, Mustafa [2 ,3 ]
Uddin, Naseem [1 ,3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA
[3] Childrens Hlth, Dallas, TX USA
关键词
spindle cell/sclerosing rhabdomyosarcoma; PAX8; PPARG; PPAR gamma; PAX8::PPARG; gene fusion; ALVEOLAR RHABDOMYOSARCOMA; CELL; REGULATORS;
D O I
10.1177/10668969221095170
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The spindle cell/sclerosing subtype of rhabdomyosarcoma is classified based on genetic features into the three categories of MYODI-mutated, gene fusion-driven, and a subset without a currently identified genetic driver event. The gene fusion-driven spindle cell/sclerosing rhabdomyosarcomas are heterogenous and characterized by increasing numbers of gene fusions, the most common gene partners being VGLL2, NCOA2, and TFCP2. Here we report a spindle cell/sclerosing rhabdomyosarcoma that arose in the orbit of a 4-year-old male. This tumor harbored a unique PAX8::PPARG fusion. PAX8::PPARG fusions have previously only been described in follicular thyroid carcinoma and follicular variant of papillary thyroid carcinoma. Our report adds to the growing number of gene fusions in spindle cell/sclerosing rhabdomyosarcomas.
引用
收藏
页码:950 / 955
页数:6
相关论文
共 50 条
  • [41] PAX8 Expression in Sarcomas: An Immunohistochemical Study
    Tjionas, George A.
    Rosenberg, Andrew E.
    Cassidy, Daniel P.
    Pinto, Andre
    MODERN PATHOLOGY, 2017, 30 : 25A - 25A
  • [42] PAX8 expression in human bladder cancer
    Pellizzari, Lucia
    Puppin, Cinzia
    Mariuzzi, Laura
    Saro, Francesca
    Pandolfi, Maura
    Di Lauro, Roberto
    Beltrami, Carlo Alberto
    Damante, Giuseppe
    ONCOLOGY REPORTS, 2006, 16 (05) : 1015 - 1020
  • [43] Investigating PAX8 interactions in ovarian cancer
    Sereti, Kostianna
    Russo, Anna
    Raisner, Ryan
    Gascoigne, Karen
    CANCER RESEARCH, 2024, 84 (06)
  • [44] PAX8 in the Junction between Development and Tumorigenesis
    Kakun, Reli Rachel
    Melamed, Zohar
    Perets, Ruth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [45] Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology
    Knoepp, Stewart M.
    Kunju, Lakshmi P.
    Roh, Michael H.
    DIAGNOSTIC CYTOPATHOLOGY, 2012, 40 (08) : 667 - 672
  • [46] Utility of PAX8 and PAX2 Immunohistochemistry in the Diagnosis of Renal Cell Carcinoma in Cytology Specimens
    Knoepp, S. M.
    Kunju, L. P.
    Roh, M. H.
    LABORATORY INVESTIGATION, 2011, 91 : 95A - 95A
  • [47] PAX8: An additional marker for kidney tumors
    Yu, W. M.
    Hamele-Bena, D.
    Memeo, L.
    Mansukhani, M.
    Tong, G-X
    LABORATORY INVESTIGATION, 2008, 88 : 192A - 192A
  • [48] PAX8, an Emerging Player in Ovarian Cancer
    Gokulnath, Priyanka
    Soriano, Amata Amy
    de Cristofaro, Tiziana
    Di Palma, Tina
    Zannini, Mariastella
    OVARIAN CANCER: MOLECULAR & DIAGNOSTIC IMAGING AND TREATMENT STRATEGIES, 2021, 1330 : 95 - 112
  • [49] Role of Pax8 in the migratory/invasive behaviour of thyroid cancer cell lines
    Ruiz-Llorente, S.
    Martin-Duque, P.
    Santisteban, P.
    HORMONE RESEARCH, 2007, 68 : 47 - 47
  • [50] Immunohistochemical expression of PAX8, PAX2, and cytokeratin in melanomas
    Plotzke, Jaclyn M.
    Zhao, Raymond
    Hrycaj, Steven M.
    Harms, Paul W.
    Mehra, Rohit
    Chan, May P.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (10) : 1246 - 1251